SG biotech startup Hummingbird Bioscience bags $125m Series C funding
SG biotech startup Hummingbird Bioscience bags $125m Series C funding Antibody visual sourced from Hummingbird's website May 18, 2021 Singapore-based biotech startup Hummingbird Bioscience has announced raising $125 million in a Series C funding round led by life science investor Novo Holdings. A syndicate of international biotech investors also participated in the funding round, including Frazier Healthcare Partners, Octagon Capital, EDBI, AMGEN Ventures, and existing investors SK Inc, Heritas Capital, and Mirae Asset Venture Capital, and others. The biotech startup, which raised $25 million...